Literature DB >> 9486089

Renovascular hypertension with low-to-normal plasma renin: clinical and angiographic features.

G P Rossi1, E Pavan, M Chiesura-Corona, M Bader, G Paganini, M Cesari, R De Toni, G P Feltrin, D Ganten, A C Pessina.   

Abstract

1. Low-to-normal renin renovascular hypertension (RVH) and the accuracy of renal vein renin ratios were investigated in 129 consecutive patients referred for suspected RVH. Forty-nine had essential hypertension, 24 unilateral renoparenchymal hypertension and 56 renal artery obstruction. Of the latter, 86% were diagnosed retrospectively as RVH, based on fall in blood pressure with correction of renal ischaemia. We measured baseline, captopril-stimulated and renal vein plasma renin activity (PRA) levels, as well as several other parameters. 2. PRA was low-to-normal in 37% of the RVH patients [low-to-normal renin (LNR-) RVH group] and elevated in the remaining 63% [high-renin (HR-) RVH group]. In the LNR-RVH group, low-to-normal renin levels, by immunoreactive active renin and plasma renin concentration measurements, and a blunted response of PRA to captopril, were seen. As compared with HR-RVH, LNR-RVH patients had a longer duration of hypertension (P < 0.05), higher serum K+ (P = 0.04) and lower diastolic blood pressure (P = 0.02). However, they did not differ for the other variables, including the fall in blood pressure after correction of renal ischaemia. Although the number of bilateral stenoses was similar in the two groups, no patient in the LNR-RVH group had total renal artery occlusion compared with 53% in the HR-RVH group (P = 0.00015). The accuracy of renal vein renin indices were high enough to justify their use only in the patients with total occlusion of a renal artery. 3. Thus LNR-RVH is common in patients with longstanding hypertension without a totally occluded renal artery. Since the sensitivity of renin measurements is low, cure of hypertension would be precluded for more than one third of RVH patients, if these tests were a prerequisite for identifying RVH.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9486089     DOI: 10.1042/cs0930435

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  Endothelin-a receptor antagonism after renal angioplasty enhances renal recovery in renovascular disease.

Authors:  Alejandro R Chade; Nathan Tullos; Nicholas J Stewart; Bret Surles
Journal:  J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 10.121

2.  Successful Depressor Effect Concomitant with Complete Normalization of High Renin and Aldosterone Profile by Percutaneous Transluminal Renal Angioplasty in a Patient with Acute Exacerbated Heart Failure with Preserved Ejection Fraction.

Authors:  Yosuke Takamiya; Keisuke Okamura; Kazuyuki Shirai; Hidenori Urata
Journal:  Am J Case Rep       Date:  2019-11-16

3.  Concurrent Primary Aldosteronism and Renal Artery Stenosis: An Overlooked Condition Inducing Resistant Hypertension.

Authors:  Lin Zhao; Jinhong Xue; Yi Zhou; Xueqi Dong; Fang Luo; Xiongjing Jiang; Xinping Du; Xianliang Zhou; Xu Meng
Journal:  Front Cardiovasc Med       Date:  2022-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.